RUNX3 is a novel negative regulator of oncogenic TEAD-YAP complex in gastric cancer

Y Qiao1, S J Lin2, Y Chen1

  • 1Cancer Science Institute of Singapore, National University of Singapore, Singapore.

Oncogene
|September 15, 2015
PubMed

Insights

Runt-related transcription factor 3 (RUNX3) suppresses tumors by inhibiting the TEAD-YAP complex, a key driver of cancer cell proliferation. This interaction is crucial for its tumor suppressor function in gastric cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Runt-related transcription factor 3 (RUNX3) is a known tumor suppressor frequently inactivated in gastric cancer.
  • The TEAD-YAP complex is a potent regulator of proliferative genes and is hyperactivated in various cancers, including liver and breast cancer.

Purpose of the Study:

  • To elucidate a novel mechanism of RUNX3 tumor suppressor activity involving the TEAD-YAP complex in gastric cancer.
  • To investigate the role of TEAD-YAP complex hyperactivation in gastric carcinogenesis and its correlation with patient survival.

Main Methods:

  • Investigated the physical interaction between RUNX3 and the TEAD-YAP complex using molecular biology techniques.
  • Assessed the impact of RUNX3-TEAD interaction on TEAD DNA-binding ability and downstream signaling.
  • Analyzed RUNX3 mutations, specifically R122C, for their effect on RUNX3-TEAD interaction.

Main Results:

  • The TEAD-YAP complex exhibits strong oncogenic activity in gastric epithelial cells and its increased expression correlates with poorer patient survival.
  • RUNX3 directly binds to the N-terminal region of TEAD, reducing its DNA-binding ability and attenuating TEAD-YAP signaling.
  • A known gastric cancer mutation (RUNX3 R122C) impairs the interaction between RUNX3 and TEAD.

Conclusions:

  • RUNX3 functions as a tumor suppressor in gastric carcinogenesis by negatively regulating the oncogenic TEAD-YAP complex.
  • Targeting the RUNX3-TEAD interaction could represent a novel therapeutic strategy for gastric cancer.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
39.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.3K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K